EX-23.1 2 eh220242905_ex2301.htm EXHIBIT 23.1

 

EXHIBIT 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the registration statement (No. 333-259336) on Form S-1 of our report dated March 31, 2022, with respect to the consolidated financial statements of NRX Pharmaceuticals, Inc.

/s/ KPMG LLP

 

Short Hills, NJ

April 8, 2022